Protagonist Corp (PTGX) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
Protagonist Therapeutics (PTGX) uchun joriy narx harakati Dinesh Patel rahbarligida inyeksiyalarni tabletka ko'rinishidagi almashtiruvchi texnologiyani ishlab chiqqan kompaniyaning natijalarini aks ettiradi. Biznes peptid agentlarining tijorat tatbiqiga tayanadi, bunda rusfertide ning ishga tushirilishi va J&J dan keladigan royalti to'lovlari asosiy o'sish drayverlari vazifasini o'taydi. Qarzning kapitalga nisbati 0.01 darajasida bo'lib, moliyaviy holat doimiy mahsulot sotuvlaridan ko'ra kontragentlardan kelgan transhlarga asoslangan.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_PTGX_-_Protagonist-Therapeutics_-_Long-Term-Debt-to-Capital "PTGX: Protagonist Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 31.10.2026 | 👁️GURU.Markets👁️")
Protagonist Therapeutics (PTGX) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Protagonist Therapeutics|PTGX - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati protagonist-inc.com|PTGX - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Protagonist|PTGX - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Protagonist Therapeutics|Tezkor likvidlik ko‘rsatkichi protagonist-inc.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:Protagonist Therapeutics, Inc. - PTGX
Ushbu koeffitsiyent kompaniyaning bir yildan ortiq muddatli qarzlarga nisbatan kapitalga bog'liqlik darajasini aniqlaydi va tuzilmaning moliyaviy barqarorligini aks ettiradi. Ushbu uzoq muddatli kredit yuki tahlili orqali investor haqiqiy qarz yukini ko'radi, bu esa Protagonist Therapeutics (PTGX) uchun og'ir immun patologiyalarini davolashga mo'ljallangan qimmat oral peptid dori vositalarini ishlab chiqishni moliyalashtirishda juda muhimdir.
Muhim raqobatchilar
argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati immunovant.com IMVT|KNSA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti GRFS (Grifols SA)|Adaptive Biotechnologies Corp (ADPT) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Celldex Corp|AUPH (Aurinia Pharmaceuticals) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati biocryst.com|Uzoq muddatli qarzning o'z kapitaliga nisbati VERA (Vera Therapeutics)|DNTH (Dianthus Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati PHVS (Pharvaris Corp)|Uzoq muddatli qarzdorlikning kapitalga nisbati AbCellera (ABCL)|TRML - Uzoq muddatli qarzning o'z kapitaliga nisbati|precigen.com (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Pharming Group (PHAR) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Nektar Therapeutics Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati UPB|Uzoq muddatli qarzning kapitalga nisbati Zenas Corp|Uzoq muddatli qarzning o'z kapitaliga nisbati Immunome, Inc. (IMNM)|gossamerbio.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Uzoq muddatli majburiyatlarning kapitalga nisbati|PVLA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati SVRA|Rigel Pharmaceuticals (RIGL) - Uzoq muddatli qarzning o'z kapitaliga nisbati|anaptysbio.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Astria Therapeutics, Inc.|Uzoq muddatli majburiyatlarning kapitalga nisbati enGene Holdings Inc ENGN|Uzoq muddatli qarzning o'z kapitaliga nisbati RAPT (RAPT Therapeutics, Inc.)|Uzoq muddatli kreditlarning kapitalga nisbati JBIO|Uzoq muddatli qarzning kapitalga nisbati ACRS (Aclaris Therapeutics)|Uzoq muddatli qarzning kapitalga nisbati kyvernatx.com KYTX|Tiziana Life Sciences Ltd - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati Cabaletta Bio Inc. (CABA)|Ventyx Bio (VTYX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Theratechnologies, Inc (THTX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Avalo Therapeutics, Inc|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi ELDN (eledon.com)|Uzoq muddatli qarzning kapitalga nisbati AGEN|Uzoq muddatli qarzdorlikning kapitalga nisbati Climb Bio Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Zura Bio Limited ZURA|Uzoq muddatli qarzdorlikning kapitalga nisbati aTyr Pharmaceuticals (ATYR)|ADAG: Uzoq muddatli qarzning o'z kapitaliga nisbati|ImageneBio Inc - Uzoq muddatli kreditlarning kapitalga nisbati|STTK (shattucklabs.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Equillium - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati CNTB|IMUX (Immunic Inc) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ATRA|IFRX (inflarx.de) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati XFOR (X4 Pharmaceuticals, Inc.)|Adicet Bio Inc. (ACET) - Uzoq muddatli majburiyatlarning kapitalga nisbati|CELU - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti INMB (INmune Bio Corporation)|BRNS: Uzoq muddatli qarzning kapitalga nisbati|kezarlifesciences.com (KZR) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati SAB Biotherapeutics, Inc.|Akari Therapeutics PLC - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ENLV|QTTB - Uzoq muddatli majburiyatlarning kapitalga nisbati|GeoVax Labs, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati edesabiotech.com EDSA|IBIO: Uzoq muddatli qarzning o'z kapitaliga nisbati|Carisma Therapeutics - Uzoq muddatli kreditlarning kapitalga nisbati|XTLB: Uzoq muddatli qarzning kapitalga nisbati|BOLT - Uzoq muddatli qarzdorlikning kapitalga nisbati|HCWB (HCW Biologics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Aptevo (APVO)|Uzoq muddatli qarzning o'z kapitaliga nisbati AIM ImmunoTech (AIM)|Uzoq muddatli qarzdorlikning kapitalga nisbati aditxt.com|Uzoq muddatli qarzning o'z kapitaliga nisbati GRI Bio Corp GRI|XRTX (XORTX Corp) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|HIND: Uzoq muddatli qarzning o'z kapitaliga nisbati|revbiosciences.com - Uzoq muddatli kreditlarning kapitalga nisbati|INDP: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati Scinai Immunotherapeutics Ltd SCNI|Uzoq muddatli qarzning o'z kapitaliga nisbati CALI|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi AFMD (Affimed Therapeutics)|Uzoq muddatli qarzning o'z kapitaliga nisbati Allakos Inc. (ALLK)|HOOK: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati IGMS (IGM Biosciences)|Uzoq muddatli qarzning kapitalga koeffitsiyenti ITOS|Ocean Bio - Uzoq muddatli qarzning kapitalga nisbati|TCBP - Uzoq muddatli qarzning kapitalga nisbati|Third Harmonic Bio (THRD) - Uzoq muddatli qarzning o'z kapitaliga nisbati